Caryl and Israel Englander
Institute for Precision Medicine

You are here

what is precision medicine?

News

Latest news from The Englander Institute for Precision Medicine:

 

March 22, 2017
Combining genetic information from a patient’s tumor cells with three-dimensional cell cultures grown from these tumors and rapidly screening approved drugs can identify the best treatment approaches in patients for whom multiple therapies have failed, according to a new study led by Weill Cornell Medicine investigators.
March 13, 2017

A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease’s development and growth, according to research from Weill Cornell Medicine scientists. Their findings could pave the way for new targeted treatment approaches.


March 8, 2017

Weill Cornell Medicine researchers will receive a grant from the Department of Defense to conduct an in-depth study of the molecular machinery driving the most aggressive form of prostate cancer.


March 1, 2017

Bishoy Faltas, MBBCh, Instructor in Medicine at Weill Cornell Medicine, was named a NextGen Star of the American Association for Cancer Research (AACR), an award that supporting the development and professional advancement of early-career scientists in cancer research.  Dr.


February 21, 2017
Entrepreneurship at Cornell (eLab) is a diverse, university-wide program that finds and fosters the entrepreneurial spirit in participants from every college, every field, and in every stage of life. Grounded in the belief that individuals who exhibit an entrepreneurial spirit and have acquired entrepreneurial knowledge can add significant value to any working environment from the smallest startup to the largest business, from non-profits to government agencies.

Weill Cornell Medicine
Caryl and Israel Englander
Institute for Precision Medicine
413 E 69th Street
Belfer Research Building
New York, NY 10021 Phone: